Gerber Kawasaki Wealth & Investment Management decreased its holdings in shares of Docusign Inc. (NASDAQ:DOCU – Free Report) by 40.4% in the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor owned 17,010 shares of the company’s stock after selling 11,553 shares during the quarter. Gerber Kawasaki Wealth & Investment Management’s holdings in Docusign were worth $1,325,000 at the end of the most recent quarter.
Several other institutional investors also recently modified their holdings of the stock. Palogic Value Management L.P. raised its stake in Docusign by 2.2% in the first quarter. Palogic Value Management L.P. now owns 5,438 shares of the company’s stock valued at $443,000 after purchasing an additional 117 shares in the last quarter. Brooklyn Investment Group increased its holdings in shares of Docusign by 24.9% in the 1st quarter. Brooklyn Investment Group now owns 702 shares of the company’s stock worth $57,000 after buying an additional 140 shares during the last quarter. MassMutual Private Wealth & Trust FSB raised its position in shares of Docusign by 31.3% during the 2nd quarter. MassMutual Private Wealth & Trust FSB now owns 595 shares of the company’s stock valued at $46,000 after buying an additional 142 shares in the last quarter. Total Wealth Planning & Management Inc. raised its position in shares of Docusign by 4.8% during the 2nd quarter. Total Wealth Planning & Management Inc. now owns 3,170 shares of the company’s stock valued at $247,000 after buying an additional 146 shares in the last quarter. Finally, Moors & Cabot Inc. lifted its holdings in shares of Docusign by 5.7% during the 2nd quarter. Moors & Cabot Inc. now owns 2,780 shares of the company’s stock worth $217,000 after acquiring an additional 150 shares during the last quarter. 77.64% of the stock is currently owned by institutional investors.
Wall Street Analyst Weigh In
A number of research analysts recently commented on DOCU shares. JMP Securities reissued a “market outperform” rating and issued a $124.00 target price on shares of Docusign in a research note on Friday, October 3rd. Wedbush cut their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating for the company in a report on Friday. UBS Group reduced their price objective on Docusign from $85.00 to $75.00 and set a “neutral” rating on the stock in a research report on Friday. Needham & Company LLC reissued a “hold” rating on shares of Docusign in a report on Friday. Finally, Robert W. Baird dropped their target price on Docusign from $90.00 to $75.00 and set a “neutral” rating for the company in a research report on Friday. Four research analysts have rated the stock with a Buy rating and sixteen have issued a Hold rating to the company. According to MarketBeat.com, the company presently has an average rating of “Hold” and an average price target of $86.71.
Insider Buying and Selling
In related news, Director Anna Marrs sold 365 shares of the business’s stock in a transaction dated Tuesday, December 2nd. The stock was sold at an average price of $68.54, for a total transaction of $25,017.10. Following the transaction, the director owned 11,163 shares in the company, valued at $765,112.02. The trade was a 3.17% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director James A. Beer sold 450 shares of the company’s stock in a transaction that occurred on Tuesday, December 2nd. The shares were sold at an average price of $68.54, for a total value of $30,843.00. Following the transaction, the director directly owned 14,478 shares of the company’s stock, valued at $992,322.12. The trade was a 3.01% decrease in their position. The disclosure for this sale is available in the SEC filing. Insiders sold 104,076 shares of company stock valued at $7,814,461 over the last ninety days. Corporate insiders own 1.66% of the company’s stock.
Docusign Stock Up 0.6%
Shares of Docusign stock opened at $66.04 on Tuesday. The company’s fifty day simple moving average is $69.16 and its two-hundred day simple moving average is $74.96. Docusign Inc. has a 12-month low of $63.41 and a 12-month high of $106.05. The firm has a market cap of $13.28 billion, a PE ratio of 46.18, a price-to-earnings-growth ratio of 3.26 and a beta of 0.98.
Docusign Company Profile
DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.
Further Reading
- Five stocks we like better than Docusign
- Low PE Growth Stocks: Unlocking Investment Opportunities
- Top 5 Highest-Rated Dividend Stocks, According to MarketBeat
- How to Invest in Small Cap Stocks
- What Dollar Tree’s Surge and Home Depot’s Slide Say About Consumer Health
- How to Buy Gold Stock and Invest in Gold
- 3 Stocks Most Likely to Split in 2026
Want to see what other hedge funds are holding DOCU? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Docusign Inc. (NASDAQ:DOCU – Free Report).
Receive News & Ratings for Docusign Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Docusign and related companies with MarketBeat.com's FREE daily email newsletter.
